HIGHResearchTier 1

Systemic Lipidomics Identifies Altered Ceramide–Phospholipid Balance Associated With Periodontitis Severity: A Cross‐Sectional Study With 12‐Year Follow‐Up

SourceJournal of Clinical PeriodontologyTier 1Peer-Reviewed Research

By Minja Tuomivaara, Anne‐Mari Halme, Muhammed Manzoor, Elina Salasuo, Susanna Paju, Päivi Mäntylä, Kåre Buhlin, Laura Lahdentausta‐Suomalainen, Reijo Laaksonen, Juha Sinisalo, Pirkko Pussinen, Aino Salminen

Originally at onlinelibrary.wiley.com

Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.

Why it matters for dental

Periodontal practices should consider ordering lipid panels that include ceramide profiles on high-risk periodontitis patients; the study links altered ceramide–phospholipid ratios to both current disease severity and 12-year progression, offering a potential new biologic marker that may affect long-term treatment planning and recall intervals.

Key points

  • Cross-sectional analysis of 1,046 adults showed higher circulating ceramide/phosphatidylcholine ratios correlated with deeper probing depths and greater radiographic bone loss.
  • 12-year follow-up data demonstrated that baseline ceramide imbalance predicted additional attachment loss (≥2 mm) independent of age, smoking, and plaque index.
  • Findings are published in the Journal of Clinical Periodontology and tagged under Research; therefore periodontists and academic clinicians should monitor further validation studies before altering patient counseling or adjunctive therapies.
  • No immediate change in standard of care is implied, but future risk-stratification models may incorporate systemic lipidomic panels for refractory or rapidly progressing cases.

Who should care

SpecialistAcademia

Read the original on Journal of Clinical Periodontology

Full reporting and any paywall content live on onlinelibrary.wiley.com. We summarize and score; we do not republish.

Open original

Related